Dr. Lorraine Chalifour
Associate Professor - Department of Medicine, Division of Experimental Medicine
1. Impact of bisphenol A as a model estrogenic disruptor on remodeling and survival post-myocardial infarction.
2. Changes in the epigenome in the heart as a consequence of long term exposure to estrogenic endocrine disruptors such as bisphenol A.
3. Cardiac fibroblast to myofibroblast transition in the presence of endocrine disruptor exposure in vitro and in vivo.